Julius Clinical invites you to their event
About this event
On October 10, at 17.00 CEST, we will present the webinar:
Anti-amyloid immunotherapies in Alzheimer's disease: finally a disease-modifying treatment?
The recent success of Anti-amyloid immunotherapy trials have initiated new debates. During this webinar, Dr. Nicolas Villain will discuss the complexity of translating early AD clinical trial results into clinical practice. Current evidence for and against Disease Modification by Anti-amyloid immunotherapy. And next steps for trials of Anti-amyloid immunotherapries in early AD.
Points that will be discussed during this webinar:
Speaker: Dr. Nicolas Villain, MD PhD - Associate Professor of Neurology (tenured position) at Sorbonne University, working at the Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France.
Host: Lieza Exalto - Scientific Officer at Julius Clinical
Julius Clinical is a global therapeutically specialized CRO that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.
